2020 ATTENDEES
2020 participants registered up to 29.09.2020:
+ND Capital (FKA NanoDimension) |
AbbVie |
Ability Pharma |
Additio Investment Group |
Abvance |
Advent France Biotechnology |
AKRN Scientific Consulting |
AlgaEnergy |
Alladvice Regulatory Consultants |
Alta Life Sciences |
Amadix |
Andera Partners |
Angels Sante |
Angiotheragnostics |
ANQUOR Corporate Finance |
APRE |
ARCH Venture Partners |
Achivel Farma |
Arquimea Group |
Arrays for Cell Nanodevices |
Arthex Biotech. |
Asabys Partners |
ASCRI – The Spanish Venture Capital & Private Equity Association |
AseBio – Spanish Bioindustry Association |
Astanor Ventures |
Aticeo |
Atrys Health |
Aurora TT |
Ayming |
Basque Health Cluster |
Basque Trade & Investment |
BDI Biotech |
Beable Capital |
BIOCAT |
Biocrew Life Sciences |
Biocrosmo |
BIOGA |
Biogeneration Ventures |
Biohealth Management |
BIOIB – Cluster Biotecnologic i Biomèdic de les Illes Balears |
Bionos Biotech |
Bio Optical Detection |
Biopolo La Fe |
Bioquochem |
BIOVAL |
Biovegen |
BME – MAB Spanish Stock Exchange |
BME GROWTH MARKET |
Business Angels – WA4STEAM |
Centro Andaluz de Biología Molecular & Medicina Regenerativa (Cabimer) |
Caixa Capital Risc |
Cancerappy |
Capital Cell |
Cells For Cells |
CIBER |
CIC nanoGUNE |
Clave Mayor |
Clinical Research Ventures |
CoBioRes |
Columbus Venture Partners |
Consulate of Canada |
Corify Care |
Cornea Project |
Crazy Science & Business |
CRB Inverbio |
CTI Life Sciences |
CZ Vaccines |
Deneb Medical |
DNA Advisory |
DOITplenoptic |
Droplite |
EIT Health Investor Network |
Eli Lilly & Company |
Embassy of Spain in UK |
Epidisease |
Eurasanté |
Euronext |
European Commission |
Eversens |
Facultas Partners Iberia |
FI Group |
Fisevi |
Flanders Trade & Investment |
FMG Ventures |
Forbion |
Fountain Healthcare Partners |
FSP CNIO |
Fund+ |
Fundación Kaertor |
Fundació Ship2b |
Fundación PCM |
Fundación Progreso y Salud |
FVA |
Gate2Brain |
Genesis Biomed |
Gistem Research |
Gómez-Acebo & Pombo |
Hadean Ventures |
Health Innovation Technology Transfer S.L. (HiTT) |
Highlight Therapeutics |
Histocell |
ICE – Instituto para la Competitividad Empresarial |
ICEX |
Immuni Therapeutics |
Inhibitec |
InnoUp |
Instituto Biomar |
Insud Pharma |
Intesa San Paolo |
Inveready |
Invest in Spain |
Invivo Capital Partners |
IPF Ventures |
Johnson & Johnson Innovation |
Joyance Partners |
Kaudal |
Keensight Capital |
Kurma Partners |
La Bolsa Social |
LafargeHolcim |
Leadartis |
LentiStem Biotech |
Leukos Biotech |
Limnopharma |
M Ventures |
Massnex |
Mecwins |
Medicxi |
Merck, Sharp & Dohme |
Ministerio de Ciencia e Innovación |
Nanodreams |
Nanoligent |
Neurofix Pharma |
Nina Capital |
Notion |
Nucaps Nanotechnology |
Numat Medtech |
OIAO – Organización Interprofesional del Aceite de Oliva |
Omnes Capital |
Oncoheroes Biosciences |
Oncomatrix |
Onena Medicines |
Optum Ventures |
Peaches Biotech |
Pedal Consulting |
Pharma Capital Partners |
Protein Alternatives |
PTS Granada |
QPlan |
Quimatryx |
Remab Therapeutics |
Remiges Ventures |
Renalyse |
Roivant Sciences |
Roka Furadada |
Scorpio Therapeutics |
Sodena |
Spotless & Stem Care Company |
Sunbo Angel Partners |
SunRock Biopharma |
Telum Therapeutics |
Tetraneuron |
Trillium Medical Ventures |
Universidad de Córdoba |
Universitat Pompeu Fabra |
University of Santiago de Compostela |
UPF Ventures |
Vaxdyn |
Ventac Partners |
Vive Biotech |
Vivotecnia Research |
XesGalicia |
Xunta de Galicia – GAIN |
Ysios Capital |
Yuhan USA |